Navigation Links
EMBO Gold Medal 2012 awarded to Jiri Friml
Date:6/27/2012

Friml receives the award for defining how the plant hormone auxin functions to regulate plant development. He was also recognized for showing how the auxin-governed molecular processes optimise adaptation of plant development and growth to ever-changing environmental conditions. The 39-year-old scientist has published more than 130 original research publications and reviews in top international journals and belongs to the most cited plant biologists worldwide.

"His groundbreaking results influence and continue to shape present and future efforts in a number of areas of plant biology research," stated EMBO Member Ferenc Nagy. The results of Friml's research are of major importance to agriculture as they provide a basis for targeted engineering that could lead to the development of plants that produce higher yields or which are more resistant to drought.

"Being awarded by my peers from EMBO is an immense honour and gives me great encouragement for my further work. I would like to think that this award is not only for me but also in a wider sense for plant research which deserves more support and could definitely benefit from more awareness," said the Gold Medal winner.

Jiř Friml's research highlights include:

  • Showing that transport-dependent morphogenetic auxin gradients and maxima underlie processes such as embryonal development, formation of all plant organs, differentiation and regeneration of tissues as well as responses to external signals such as light and gravity
  • Establishing the concept that auxin acts as a versatile trigger providing spatial and temporal information to reprogram cellular behavior
  • Demonstrating the clathrin-mediated mechanism of endocytosis in plants along with the developmental significance of this process in the field of plant cell biology
  • Revealing mechanisms that govern cell polarity in plants and its importance for both hormonal signaling and development


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Quintessa Medical ... Kybella is a nonsurgical treatment designed specifically for the elimination of excess ... of the first locations in the state of Wisconsin to offer this innovative treatment. ...
(Date:7/30/2015)... ... 30, 2015 , ... The Tisch Cancer Institute at Icahn ... Tisch Cancer Institute (TCI) at the Icahn School of Medicine at Mount Sinai ... elite group of 69 cancer institutions nationwide that have earned this designation, which ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos seeks ... in his new self-help book, “ Consciously Healing our Webs of Health, Wellbeing, Success, ... message: “If we take responsibility for ourselves, we can create better realities.” His book ...
(Date:7/30/2015)... ... 30, 2015 , ... WellSpan Health in York, Pa., has ... claims for bariatric surgery that, despite complying with national and local coverage determinations, ... nurse auditor at WellSpan Health, tells Atlantic Information Services’ (AIS) Report on Medicare ...
(Date:7/30/2015)... ... ... weight, many people place a lot of focus on the different types of food that need ... another key component to successful weight gain is knowing when to eat so that ... Gainer gives three tips on when to eat to gain weight. , The first thing ...
Breaking Medicine News(10 mins):Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3
... a part of National Health Service (NHS) that offers support to ... has decided// to cut hundreds of jobs as part of a ... going on about the issue. But unions fear that as many ... set up eight years ago as a new approach to take ...
... that periodontal disease is not a desirable condition in ... the first time researchers from Case Western Reserve University ... and Gynecology at MetroHealth Medical Center in Cleveland have ... ,Their report, titles, "Transmission of an Uncultivated Bergeyella Strain ...
... India the Reserve Bank of India (RBI) is not allowing ... and the State Bank of India (SBI) // facing difficulties ... , The Comprehensive Economic Cooperation Agreement (CECA) that was ... The Monetary Authority of Singapore (MAS), or central bank, ...
... people who suffer whiplash injuries can recover soon with ... Quebec, Canada.// The Whiplash Management strategy is a big ... initiative being better cost economy and earlier resumption of ... target, better practices in management of patient care that ...
... with inherited retinal degeneration have hope of vision since ... light sensitive that were not before.// ,Zhuo-Hua ... colleagues have engineered this technology using a harmless virus, ... "inner retinal neurons" in a strain of mice with ...
... of Kaiser Permanente, overweight or obesity during one’s middle ... in life. ,'The study was presented during ... San Diego. ,The researchers from the Kaiser ... 9,000 people for a period of 30 years. ...
Cached Medicine News:Health News:Strained Economic Agreement Between Singapore And India 2Health News:There is light at the end of the blind tunnel: prosthetic retinal cells offer hope! 2
(Date:7/30/2015)... 2015   HeartWare International, Inc . (NASDAQ: ... invasive, miniaturized circulatory support technologies that are revolutionizing ... total revenue of $73.6 million for the quarter ... for the quarter ended June 30, 2014.  Currency ... or nine percentage points, during the three months ...
(Date:7/30/2015)... Maine, July 30, 2015  IDEXX Laboratories, Inc. (NASDAQ: ... quarter of 2015 of $413 million, an increase of ... the strengthening of the US dollar reduced reported revenue ... for the quarter was 11%, supported by strong growth ... per diluted share ("EPS") was $0.60 for the quarter, ...
(Date:7/29/2015)... FRANCISCO , July 29, 2015 Dignity ... Francis Orthopedic Institute, combining the services of the hospital,s ... in one centralized location, and expanding services to include ... the street from Saint Francis Memorial Hospital at 1199 ... Institute is a premier center aimed at providing a ...
Breaking Medicine Technology:HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23
...   , First once-daily, fixed-dose ... (an irregular heartbeat) at risk of the devastating consequences ... single drug solution for the treatment of deep vein ... Xarelto is now approved in the UK for ...
... 19, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Products for Human Use (CHMP) of the European Medicines ... facility expansion in Novato, CA.  Final approval by the ... which would allow for products manufactured at the facility ...
Cached Medicine Technology:Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 2Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 3Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 5Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 6BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility 2BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility 3